Long Non-coding RNA BGas Regulates the Cystic Fibrosis Transmembrane Conductance Regulator
Cystic fibrosis (CF) is a life-shortening genetic disease. The root cause of CF is heritable recessive mutations that affect the cystic fibrosis transmembrance conductance regulator (CFTR) gene and the subsequent expression and activity of encoded ion channels at the cell surface. We show that CFTR...
Gespeichert in:
Veröffentlicht in: | Molecular therapy 2016-08, Vol.24 (8), p.1351-1357 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1357 |
---|---|
container_issue | 8 |
container_start_page | 1351 |
container_title | Molecular therapy |
container_volume | 24 |
creator | Saayman, Sheena M Ackley, Amanda Burdach, Jon Clemson, Matthew Gruenert, Dieter C Tachikawa, Kiyoshi Chivukula, Pad Weinberg, Marc S Morris, Kevin V |
description | Cystic fibrosis (CF) is a life-shortening genetic disease. The root cause of CF is heritable recessive mutations that affect the cystic fibrosis transmembrance conductance regulator (CFTR) gene and the subsequent expression and activity of encoded ion channels at the cell surface. We show that CFTR is regulated transcriptionally by the actions of a novel long noncoding RNA (lncRNA), designated as BGas, that emanates from intron 11 of the CFTR gene and is expressed in the antisense orientation relative to the protein coding sense strand. We find that BGas functions in concert with several proteins including HMGA1, HMGB1, and WIBG to modulate the local chromatin and DNA architecture of intron 11 of the CFTR gene and thereby affects transcription. Suppression of BGas or its associated proteins results in a gain of both CFTR expression and chloride ion function. The observations described here highlight a previously underappreciated mechanism of transcriptional control and suggest that BGas may serve as a therapeutic target for specifically activating expression of CFTR. |
doi_str_mv | 10.1038/mt.2016.112 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5023374</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1525001616335869</els_id><sourcerecordid>4175740931</sourcerecordid><originalsourceid>FETCH-LOGICAL-c488t-bb9c4ffd7f050988384ca39b5140518b475f5f406629f9a61c260b6a8d7323843</originalsourceid><addsrcrecordid>eNqNkc9LHDEcxUNR6nbbU-8y4KVQZs3vSS4Fu6gVFgXZXnoJmUxmjcxM1iQj-N-bYXVppQdP3wffTx75vgfAVwQXCBJx2qcFhogvEMIfwAwxzEoIMT3Ya8SPwKcY77NCTPKP4AhXlFAmxAz8WflhU1z7oTS-cVneXp8VPy91LG7tZux0srFId7ZYPsXkTHHh6uCji8U66CH2tq_zzFs_NKNJejD29Z0Pn8Fhq7tov7zMOfh9cb5e_ipXN5dXy7NVaagQqaxraWjbNlULGZRCEEGNJrJmiEKGRE0r1rKWQs6xbKXmyGAOa65FUxGcYTIHP3a-27HubWPskILu1Da4Xocn5bVT_24Gd6c2_lExiAmpJoNvLwbBP4w2JtW7aGzX5dP8GBUSSCIiMBTvQZmsKJdVRk_eoPd-DENOYqIqwSnlk-H3HWVyrjHYdv9vBNVUr-qTmupVud5MH_996p597TMDbAfYHPijs0FF42yupXHBmqQa7_5r_Ay4wLDl</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1817864468</pqid></control><display><type>article</type><title>Long Non-coding RNA BGas Regulates the Cystic Fibrosis Transmembrane Conductance Regulator</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ProQuest Central UK/Ireland</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Saayman, Sheena M ; Ackley, Amanda ; Burdach, Jon ; Clemson, Matthew ; Gruenert, Dieter C ; Tachikawa, Kiyoshi ; Chivukula, Pad ; Weinberg, Marc S ; Morris, Kevin V</creator><creatorcontrib>Saayman, Sheena M ; Ackley, Amanda ; Burdach, Jon ; Clemson, Matthew ; Gruenert, Dieter C ; Tachikawa, Kiyoshi ; Chivukula, Pad ; Weinberg, Marc S ; Morris, Kevin V</creatorcontrib><description>Cystic fibrosis (CF) is a life-shortening genetic disease. The root cause of CF is heritable recessive mutations that affect the cystic fibrosis transmembrance conductance regulator (CFTR) gene and the subsequent expression and activity of encoded ion channels at the cell surface. We show that CFTR is regulated transcriptionally by the actions of a novel long noncoding RNA (lncRNA), designated as BGas, that emanates from intron 11 of the CFTR gene and is expressed in the antisense orientation relative to the protein coding sense strand. We find that BGas functions in concert with several proteins including HMGA1, HMGB1, and WIBG to modulate the local chromatin and DNA architecture of intron 11 of the CFTR gene and thereby affects transcription. Suppression of BGas or its associated proteins results in a gain of both CFTR expression and chloride ion function. The observations described here highlight a previously underappreciated mechanism of transcriptional control and suggest that BGas may serve as a therapeutic target for specifically activating expression of CFTR.</description><identifier>ISSN: 1525-0016</identifier><identifier>EISSN: 1525-0024</identifier><identifier>DOI: 10.1038/mt.2016.112</identifier><identifier>PMID: 27434588</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Cystic fibrosis ; Cystic Fibrosis - genetics ; Cystic Fibrosis - metabolism ; Cystic Fibrosis Transmembrane Conductance Regulator - genetics ; DNA methylation ; DNA-Binding Proteins - metabolism ; Epigenetics ; Gene expression ; Gene Expression Regulation ; Gene therapy ; Genetic Loci ; Genomes ; Genotype & phenotype ; Humans ; Localization ; Medicine ; Models, Biological ; Mutation ; Original ; Protein Binding ; Proteins ; Research centers ; RNA, Antisense - genetics ; RNA, Long Noncoding</subject><ispartof>Molecular therapy, 2016-08, Vol.24 (8), p.1351-1357</ispartof><rights>2016 Official journal of the American Society of Gene & Cell Therapy</rights><rights>Copyright Nature Publishing Group Aug 2016</rights><rights>Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy 2016 Official journal of the American Society of Gene & Cell Therapy</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c488t-bb9c4ffd7f050988384ca39b5140518b475f5f406629f9a61c260b6a8d7323843</citedby><cites>FETCH-LOGICAL-c488t-bb9c4ffd7f050988384ca39b5140518b475f5f406629f9a61c260b6a8d7323843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023374/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1817864468?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,315,728,781,785,886,27929,27930,53796,53798,64390,64392,64394,72474</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27434588$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saayman, Sheena M</creatorcontrib><creatorcontrib>Ackley, Amanda</creatorcontrib><creatorcontrib>Burdach, Jon</creatorcontrib><creatorcontrib>Clemson, Matthew</creatorcontrib><creatorcontrib>Gruenert, Dieter C</creatorcontrib><creatorcontrib>Tachikawa, Kiyoshi</creatorcontrib><creatorcontrib>Chivukula, Pad</creatorcontrib><creatorcontrib>Weinberg, Marc S</creatorcontrib><creatorcontrib>Morris, Kevin V</creatorcontrib><title>Long Non-coding RNA BGas Regulates the Cystic Fibrosis Transmembrane Conductance Regulator</title><title>Molecular therapy</title><addtitle>Mol Ther</addtitle><description>Cystic fibrosis (CF) is a life-shortening genetic disease. The root cause of CF is heritable recessive mutations that affect the cystic fibrosis transmembrance conductance regulator (CFTR) gene and the subsequent expression and activity of encoded ion channels at the cell surface. We show that CFTR is regulated transcriptionally by the actions of a novel long noncoding RNA (lncRNA), designated as BGas, that emanates from intron 11 of the CFTR gene and is expressed in the antisense orientation relative to the protein coding sense strand. We find that BGas functions in concert with several proteins including HMGA1, HMGB1, and WIBG to modulate the local chromatin and DNA architecture of intron 11 of the CFTR gene and thereby affects transcription. Suppression of BGas or its associated proteins results in a gain of both CFTR expression and chloride ion function. The observations described here highlight a previously underappreciated mechanism of transcriptional control and suggest that BGas may serve as a therapeutic target for specifically activating expression of CFTR.</description><subject>Cystic fibrosis</subject><subject>Cystic Fibrosis - genetics</subject><subject>Cystic Fibrosis - metabolism</subject><subject>Cystic Fibrosis Transmembrane Conductance Regulator - genetics</subject><subject>DNA methylation</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>Epigenetics</subject><subject>Gene expression</subject><subject>Gene Expression Regulation</subject><subject>Gene therapy</subject><subject>Genetic Loci</subject><subject>Genomes</subject><subject>Genotype & phenotype</subject><subject>Humans</subject><subject>Localization</subject><subject>Medicine</subject><subject>Models, Biological</subject><subject>Mutation</subject><subject>Original</subject><subject>Protein Binding</subject><subject>Proteins</subject><subject>Research centers</subject><subject>RNA, Antisense - genetics</subject><subject>RNA, Long Noncoding</subject><issn>1525-0016</issn><issn>1525-0024</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkc9LHDEcxUNR6nbbU-8y4KVQZs3vSS4Fu6gVFgXZXnoJmUxmjcxM1iQj-N-bYXVppQdP3wffTx75vgfAVwQXCBJx2qcFhogvEMIfwAwxzEoIMT3Ya8SPwKcY77NCTPKP4AhXlFAmxAz8WflhU1z7oTS-cVneXp8VPy91LG7tZux0srFId7ZYPsXkTHHh6uCji8U66CH2tq_zzFs_NKNJejD29Z0Pn8Fhq7tov7zMOfh9cb5e_ipXN5dXy7NVaagQqaxraWjbNlULGZRCEEGNJrJmiEKGRE0r1rKWQs6xbKXmyGAOa65FUxGcYTIHP3a-27HubWPskILu1Da4Xocn5bVT_24Gd6c2_lExiAmpJoNvLwbBP4w2JtW7aGzX5dP8GBUSSCIiMBTvQZmsKJdVRk_eoPd-DENOYqIqwSnlk-H3HWVyrjHYdv9vBNVUr-qTmupVud5MH_996p597TMDbAfYHPijs0FF42yupXHBmqQa7_5r_Ay4wLDl</recordid><startdate>20160801</startdate><enddate>20160801</enddate><creator>Saayman, Sheena M</creator><creator>Ackley, Amanda</creator><creator>Burdach, Jon</creator><creator>Clemson, Matthew</creator><creator>Gruenert, Dieter C</creator><creator>Tachikawa, Kiyoshi</creator><creator>Chivukula, Pad</creator><creator>Weinberg, Marc S</creator><creator>Morris, Kevin V</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><general>Nature Publishing Group</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>20160801</creationdate><title>Long Non-coding RNA BGas Regulates the Cystic Fibrosis Transmembrane Conductance Regulator</title><author>Saayman, Sheena M ; Ackley, Amanda ; Burdach, Jon ; Clemson, Matthew ; Gruenert, Dieter C ; Tachikawa, Kiyoshi ; Chivukula, Pad ; Weinberg, Marc S ; Morris, Kevin V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c488t-bb9c4ffd7f050988384ca39b5140518b475f5f406629f9a61c260b6a8d7323843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Cystic fibrosis</topic><topic>Cystic Fibrosis - genetics</topic><topic>Cystic Fibrosis - metabolism</topic><topic>Cystic Fibrosis Transmembrane Conductance Regulator - genetics</topic><topic>DNA methylation</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>Epigenetics</topic><topic>Gene expression</topic><topic>Gene Expression Regulation</topic><topic>Gene therapy</topic><topic>Genetic Loci</topic><topic>Genomes</topic><topic>Genotype & phenotype</topic><topic>Humans</topic><topic>Localization</topic><topic>Medicine</topic><topic>Models, Biological</topic><topic>Mutation</topic><topic>Original</topic><topic>Protein Binding</topic><topic>Proteins</topic><topic>Research centers</topic><topic>RNA, Antisense - genetics</topic><topic>RNA, Long Noncoding</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saayman, Sheena M</creatorcontrib><creatorcontrib>Ackley, Amanda</creatorcontrib><creatorcontrib>Burdach, Jon</creatorcontrib><creatorcontrib>Clemson, Matthew</creatorcontrib><creatorcontrib>Gruenert, Dieter C</creatorcontrib><creatorcontrib>Tachikawa, Kiyoshi</creatorcontrib><creatorcontrib>Chivukula, Pad</creatorcontrib><creatorcontrib>Weinberg, Marc S</creatorcontrib><creatorcontrib>Morris, Kevin V</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saayman, Sheena M</au><au>Ackley, Amanda</au><au>Burdach, Jon</au><au>Clemson, Matthew</au><au>Gruenert, Dieter C</au><au>Tachikawa, Kiyoshi</au><au>Chivukula, Pad</au><au>Weinberg, Marc S</au><au>Morris, Kevin V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long Non-coding RNA BGas Regulates the Cystic Fibrosis Transmembrane Conductance Regulator</atitle><jtitle>Molecular therapy</jtitle><addtitle>Mol Ther</addtitle><date>2016-08-01</date><risdate>2016</risdate><volume>24</volume><issue>8</issue><spage>1351</spage><epage>1357</epage><pages>1351-1357</pages><issn>1525-0016</issn><eissn>1525-0024</eissn><abstract>Cystic fibrosis (CF) is a life-shortening genetic disease. The root cause of CF is heritable recessive mutations that affect the cystic fibrosis transmembrance conductance regulator (CFTR) gene and the subsequent expression and activity of encoded ion channels at the cell surface. We show that CFTR is regulated transcriptionally by the actions of a novel long noncoding RNA (lncRNA), designated as BGas, that emanates from intron 11 of the CFTR gene and is expressed in the antisense orientation relative to the protein coding sense strand. We find that BGas functions in concert with several proteins including HMGA1, HMGB1, and WIBG to modulate the local chromatin and DNA architecture of intron 11 of the CFTR gene and thereby affects transcription. Suppression of BGas or its associated proteins results in a gain of both CFTR expression and chloride ion function. The observations described here highlight a previously underappreciated mechanism of transcriptional control and suggest that BGas may serve as a therapeutic target for specifically activating expression of CFTR.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27434588</pmid><doi>10.1038/mt.2016.112</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1525-0016 |
ispartof | Molecular therapy, 2016-08, Vol.24 (8), p.1351-1357 |
issn | 1525-0016 1525-0024 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5023374 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ProQuest Central UK/Ireland; PubMed Central; Alma/SFX Local Collection |
subjects | Cystic fibrosis Cystic Fibrosis - genetics Cystic Fibrosis - metabolism Cystic Fibrosis Transmembrane Conductance Regulator - genetics DNA methylation DNA-Binding Proteins - metabolism Epigenetics Gene expression Gene Expression Regulation Gene therapy Genetic Loci Genomes Genotype & phenotype Humans Localization Medicine Models, Biological Mutation Original Protein Binding Proteins Research centers RNA, Antisense - genetics RNA, Long Noncoding |
title | Long Non-coding RNA BGas Regulates the Cystic Fibrosis Transmembrane Conductance Regulator |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T12%3A07%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long%20Non-coding%20RNA%20BGas%20Regulates%20the%20Cystic%20Fibrosis%20Transmembrane%20Conductance%20Regulator&rft.jtitle=Molecular%20therapy&rft.au=Saayman,%20Sheena%20M&rft.date=2016-08-01&rft.volume=24&rft.issue=8&rft.spage=1351&rft.epage=1357&rft.pages=1351-1357&rft.issn=1525-0016&rft.eissn=1525-0024&rft_id=info:doi/10.1038/mt.2016.112&rft_dat=%3Cproquest_pubme%3E4175740931%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1817864468&rft_id=info:pmid/27434588&rft_els_id=S1525001616335869&rfr_iscdi=true |